Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsBertrand Routy, Laurence Zitvogel, Solenn Brosseau et al.|Science|2017Cited by 5.4k
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockadeGladys Ferrere, Laurence Zitvogel|JCI Insight|2020Cited by 504
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophageAurélie Fluckiger, Vincent Cattoir, Romain Daillère et al.|Science|2020Cited by 382
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Laurence Zitvogel, Takahiro Yamazaki et al.|Cell Research|2019Cited by 246
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancersMarine Fidelle, Romain Daillère, Conrad Rauber et al.|Science|2023Cited by 216